Evidence map›Paper›PMID 36980391›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Mathematical Modelling of Cervical Precancerous Lesion Grade Risk Scores: Linear Regression Analysis of Cellular Protein Biomarkers and Human Papillomavirus

Sureewan Bumrungthai, Tipaya Ekalaksananan, Pilaiwan Kleebkaow, Khajohnsilp Pongsawatkul, Pisit Phatnithikul, Jirad Jaikan, Puntanee Raumsuk, Sureewan Duangjit, Datchani Chuenchai, Chamsai Pientong

Open access · goldFull text read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sureewan BumrungthaiDivision of Biopharmacy, Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani 34190, Thailand.ORCID 0000-0003-1684-3814
Tipaya EkalaksanananHPV & EBV and Carcinogenesis Research Group, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0003-2406-2356
Pilaiwan KleebkaowDepartment of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Khajohnsilp PongsawatkulDepartment of Social Medicine, Phayao Hospital, Phayao 56000, Thailand.
Pisit PhatnithikulDepartment of Cytopathology, Phayao Hospital, Phayao 56000, Thailand.
Jirad JaikanDepartment of Cytopathology, Phayao Hospital, Phayao 56000, Thailand.
Puntanee RaumsukDepartment of Cytopathology, Phayao Hospital, Phayao 56000, Thailand.
Sureewan DuangjitDivision of Pharmaceutical Chemistry and Technology, Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani 34190, Thailand.ORCID 0000-0002-6187-9368
Datchani ChuenchaiDivision of Microbiology and Parasitology, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
Chamsai PientongHPV & EBV and Carcinogenesis Research Group, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0003-2797-043X
University of Phayao · THKhon Kaen University · THUbon Ratchathani University · TH

Funding

Thailand Research Fund (TRF) through the Royal Golden Jubilee Program RAP60K0018Thailand Science Research and Innovation (TSRI) and Research and Graduate Studies, Khon Kaen University, Thailand RP65-8-001
6 · The paper itself

Abstract

The current practice of determining histologic grade with a single molecular biomarker can facilitate differential diagnosis but cannot predict the risk of lesion progression. Cancer is caused by complex mechanisms, and no single biomarker can both make accurate diagnoses and predict progression risk. Modelling using multiple biomarkers can be used to derive scores for risk prediction. Mathematical models (MMs) may be capable of making predictions from biomarker data. Therefore, this study aimed to develop MM-based scores for predicting the risk of precancerous cervical lesion progression and identifying precancerous lesions in patients in northern Thailand by evaluating the expression of multiple biomarkers. The MMs (Models 1-5) were developed in the test sample set based on patient age range (five categories) and biomarker levels (cortactin, p16

Indexed as

biomarkercervical cancerHPVmachine learningmathematical modelrisk score

Identifiers

PMID36980391
PMCPMC10047622
OpenAlexW4324148788

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read5
measurements read90
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.